Top Markets
#1 XPIN Network XPIN Network +26.84%
#2 Geodnet Geodnet +23.03%
#3 Ore Ore +22.61%
#4 EXOD EXOD +22.08%
#5 Unit Zcash Unit Zcash +21.74%
#6 Verus Coin Verus Coin +20.46%
#7 The Black Bull The Black Bull +18.54%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +17.14%
#9 SSV Network SSV Network +16.67%
#10 Ethena Staked ENA Ethena Staked ENA +16.64%
Coin of the day
XPIN Network XPIN Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Orexo AB Orexo AB

Orexo AB

ORX
Rangering i aksjer #24889
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Aksjekurs
$1.58
Markedsverdi
$55.48M
Endring (1 dag)
0.86%
Endring (1 år)
-28.33%
Land
SE
Handel Orexo AB (ORX)

Kategori

Healthcare
Inntekter for Orexo AB (ORX)
Inntekter i 2026 TTM: 0
Ifølge Orexo AB sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Orexo AB fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK